Schedule 13D ownership disclosure

IDERA PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45168K306

Event date: 2020-07-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-222471
Form type
SC 13D/A
Filer
Aceragen, Inc.
CIK
CIK 861838
Filed
Aug 17, 2020
Reporting period
Jul 13, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub